Speaker "Alan Louie" Details Back



Driving Near Term AI Adoption in the Life Sciences


While the buzz around AI has been pervasive across numerous industries for years, attempts to deliver significant business outcomes from the use of this technology in the life sciences have fallen short after multiple attempts. Nevertheless, the next iteration of AI will represent a core component of digital transformation, with the ability to improve efficiencies throughout the lifecycle and optimize data use and sharing across the enterprise. Understanding the various phases of AI, from NLP and RPA to intelligent process automation and beyond will be key to unleashing its full potential in all parts of the life science industry, both today and in the future.
Who is this presentation for?
pharma/life science business leads


Alan is responsible for directing the IDC Health Insights Life Sciences practice. Dr. Louie manages a group of analysts who provide research-based advisory and consulting services for life sciences companies, technology vendors, and IT service providers across the life sciences value chain. Within the practice, Dr. Louie leads IDC Health Insights' Life Science R&D Strategy and Technology Research service with coverage of ongoing innovation and best practices in life science R&D and a further emphasis on technology and innovation in clinical development, analytics, translational research, and precision medicine. Dr. Louie brings more than 34 years of technology, product and strategy development from across the life science industry. Previously, Dr. Louie led applied biotechnology programs as Senior Manager at Arthur D. Little, Inc. In this role, he managed laboratory-based technology development programs, as well as provided content expertise to life science and healthcare strategy projects. Over his career, Dr. Louie was responsible for the development and commercialization of more than 30 products for a variety of industries, including many first-in-class product offerings.